MongoDB (MDB)

Software / Bases de datos / Nube

Document database platform with exceptional developer adoption and a 121% net expansion rate on recurring revenue, priced for accounting profitability that does not yet exist: No margin of safety: the price already discounts a demanding scenario., with an estimated return of -9% annually over five years.

Moat Compounder estimates the intrinsic value of MongoDB (MDB) at $234 per share on a five-year horizon. With the stock at $381.29 at 2026-10-12 close, the expected total return is -9.3% per year: overvalued. The analysis draws on 10-K FY2026 (fiscal year ended Jan 31, 2026) and 10-Q Q1 FY2027 (quarter ended Apr 30, 2026). Analysis dated 2026-09-01.

Price
$381.29
at 2026-10-12 close
Intrinsic value (5y, base)
$234
Total annual return (5y)
-9.3%
Status (nominal)
Overvalued
Margin of safety
No margin

The essentials

  • Revenue growth of 25.5% over the last twelve months, with a net expansion rate on recurring revenue of 121% showing that the installed base grows on its own.
  • Stock-based compensation equals 20.3% of revenue and 86% of free cash flow: reported cash flow is not the owner's economics, and the valuation runs on owner earnings, that is, operating cash flow net of stock-based compensation and of maintenance capital expenditure.
  • Balance sheet with no financial debt and US$2,411 million in cash and short-term investments; shares outstanding were flat in fiscal 2026 because the buyback fully absorbed issuance from awards and from the Voyage AI acquisition.
  • GAAP operating income remains negative (guided between −US$28 and −US$8 million for fiscal 2027); return on invested capital sits below the method's 10% bar.
  • At $381 per share, the estimated five-year return is -9% annually: Overvalued.
Health: Under watch
Price $381 at 2026-10-12 closeMarket Cap $31.3 bnEnterprise Value $28.9 bnNet cash $2.4 bnEV/NOPAT (at 5 years) 41.2x

Intrinsic value — two valuation methods

No margin of safety
Price market
$381
DCF value today
$206
-46.0% vs price
Multiples value today
$188
-50.8% vs price

By both methods, the value today (DCF $206 · Multiples $188) is below the market price ($381).

Pillars of the analysis

The verdict — today vs 5 years

Today — expensive, no margin of safety: at $381 trades ~103.1% above its value discounted to today (~$188); the expected return does not even reach the risk-free rate (4.5%).

At 5 years — Sobrevalorado: the expected total return is negative — the price already discounts a demanding scenario that, if not met, results in a loss.

The bridge: the return at 5 years falls below the risk-free rate (4.5%) — which is why there is not even a discount to today's value. To require a 15% annual return, it would need to be bought at ~$116.

Thesis

The business

This is a high-quality subscription business at the commercial level: capital-light, with a net expansion rate on recurring revenue of 121%, more than 65,200 customers, and revenue growth of 25.5% over the last twelve months. The objection is not about demand but about the economics that reach the shareholder: stock-based compensation equals 20.3% of revenue and consumes 86% of free cash flow, so GAAP net income has only now turned positive, nearly nine years after the IPO: after four consecutive fiscal years of GAAP losses, the first quarter of fiscal 2027 posted net income of US$4.4 million.

The valuation

It is valued at the enterprise level on a multiple of after-tax operating income, which expenses stock-based compensation. This is the metric that fits a subscription platform with no material physical capital and with that line item weighing more than a fifth of revenue. The path starts from fiscal 2027 guidance and decelerates smoothly to a durable low-double-digit growth rate by year five, with the accounting net margin rising as stock-based compensation recedes as a percentage of revenue, as it has been doing since 2023. On that basis, the five-year value is $234 per share, against a price of $381.

The margin of safety

No margin of safety: the price already discounts a demanding scenario. The estimated return at market price is -9% annually, entirely from price appreciation (-9%), because the company does not pay a dividend. To require the method's 15% annual hurdle, the maximum price to pay would be -228%. The favorable scenario, which assumes sustained growth above 17% and a cash margin net of stock-based compensation of 19.5% by year five, still does not clear the current price: it returns -9% annually.

What to watch

The disconfirming test is the trajectory of stock-based compensation as a percentage of revenue: it has been receding by about two points a year since 2023, and the entire conversion of growth into earnings depends on that continuing. The second indicator is Atlas consumption, which is billed by usage and today accounts for nearly three quarters of revenue: a slowdown in consumption shows up in remaining performance obligations before it shows up in the income statement.

Educational / informational. Does not constitute investment advice.

Other companies of the same type